REACH—Scope of the Problem: Cerebro- and Cardiovascular Disease
{"Image DocumentName": "REACH\u2014Scope of the Problem: Cerebro- and Cardiovascular Disease", "Image ImageDescription": "63% of PAD patients. had polyvascular  disease. N = Cerebro-vascular. Coronary. artery. 14.2% 39.4% 9.5% REACH (REduction of Atherothrombosis for Continued Health) is an integrated, international registry designed to focus on patients with stroke, MI, PAD, and multiple risk factors. As of July 2004, the REACH Registry has recruited over 63,000 patients from 43 countries. Bhatt and colleagues, on behalf of the REACH Registry Investigators, looked at over 7,000 patients with symptomatic PAD. They found that 63% of PAD patients had polyvascular disease, that is, concomitant symptomatic cerebrovascular or cardiovascular disease or both. It is important to note the high prevalence of polyvascular disease worldwide among patients with symptomatic PAD. Bhatt DL, Steg PG, Ohman EM, Rother J, Wilson PWF, on Behalf of the REACH Registry Investigators. Risk Profile and Undertreatment of Peripheral Arterial Disease: 7,013 Patients From the International REACH Registry. American College of Cardiology Scientific Session. March 8, Peripheral artery. Polyvascular. disease.  PAD patients with polyvascular disease had concomitant symptomatic cerebrovascular disease and/or CVD. REACH = REduction of Atherothrombosis for Continued Health. Bhatt DL et al. American College of Cardiology Scientific Session. March 8, 2005.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}